Диссертация (Связь мутаций митохондриального генома с формированием атеросклеротических поражений артериальной стенки), страница 44
Описание файла
Файл "Диссертация" внутри архива находится в папке "Связь мутаций митохондриального генома с формированием атеросклеротических поражений артериальной стенки". PDF-файл из архива "Связь мутаций митохондриального генома с формированием атеросклеротических поражений артериальной стенки", который расположен в категории "". Всё это находится в предмете "биология" из Аспирантура и докторантура, которые можно найти в файловом архиве РНИМУ им. Пирогова. Не смотря на прямую связь этого архива с РНИМУ им. Пирогова, его также можно найти и в других разделах. , а ещё этот архив представляет собой докторскую диссертацию, поэтому ещё представлен в разделе всех диссертаций на соискание учёной степени доктора биологических наук.
Просмотр PDF-файла онлайн
Текст 44 страницы из PDF
– V.121.– P.245-251.430.Naini A.B., Lu J., Kaufmann P., Bernstein R.A., Mancuso M., Bonilla E.,Hirano M., DiMauro S. Novel mitochondrial DNA ND5 mutation in a patient withclinical features of MELAS and MERRF. // Arch. Neurol. – 2005. – V.62. – Issue3. – P.473-476.431.Nakagawa Y., Ikeda K., Akakabe Y., Koide M., Uraoka M., Yutaka K.T.,Kurimoto-Nakano R., Takahashi T., Matoba S., Yamada H., Okigaki M.,Matsubara H. Paracrine osteogenic signals via bone morphogenetic protein-2accelerate the atherosclerotic intimal calcification in vivo.
// Arterioscler. Thromb.Vasc. Biol. – 2010. – V.30. – Issue 10. – P.1908-1915.432.Nakagawa Y., Ikegami H., Yamato E., Takekawa K., Fujisawa T., HamadaY., Ueda H., Uchigata Y., Miki T., Kumahara Y. A new mitochondrial DNAmutation associated with non-insulin-dependent diabetes mellitus. // Biochem.Biophys. Res. Commun. – 1995.
– V.209. – Issue 2. – P.664-668.433.Natori S., Lai S., Finn J.P., Gomes A.S., Hundley W.G., Jerosch-Herold M.,Pearson G., Sinha S., Arai A., Lima J.A., Bluemke D.A. Cardiovascular functionin multi-ethnic study of atherosclerosis: normal values by age, sex, and ethnicity.// AJR Am. J. Roentgenol. – 2006. – V.186. – Issue 6. – P.357-365.326434.Naue J., Sänger T., Schmidt U., Klein R., Lutz-Bonengel S. Factorsaffecting the detection and quantification of mitochondrial point heteroplasmyusing Sanger sequencing and SNaPshot minisequencing. // Int.
J. Legal. Med. –2011. – V.125. – Issue 3. – P.427-436.435.Nemoto M., Nishimura R., Sasaki T., Hiki Y., Miyashita Y., Nishioka M.,Fujimoto K., Sakuma T., Ohashi T., Fukuda K., Eto Y., Tajima N. Geneticassociation of glutathione peroxidase-1 with coronary artery calcification in type 2diabetes: a case control study with multi-slice computed tomography. //Cardiovasc. Diabetol. – 2007. – V.6. – P.23-30.436.Newton C. R., A. Graham, L.
E. Heptinstall, S. J. Powell, C. Summers, N.Kalsheker, J. C. Smith, and A. F. Markham. Analysis of any point mutation inDNA. The amplification refractory mutation system (ARMS). // Nucleic. AcidsRes. – 1989. – April 11; V.17. – Issue 7. – P.2503–2516.437.Newton C.R., Summers C., Schwarz M.J. et al. Amplification refractorymutation system for prenatal diagnosis and carrier assesment in cystic fibrosis. //Lancet. – 1989. – Dec.23-30; V.2. – Issue 8678-8679.
– P.1481-1483.438.Nikoskelainen E., Wanne O., Dahl M. Pre-excitation syndrome and Leber'shereditary optic neuroretinopathy. // Lancet. – 1985. – V.1. – Issue 8430. – P.696707.439. Nishigaki Y., Martí R., Copeland W.C., Hirano M. Site-specific somaticmitochondrial DNA point mutations in patients with thymidine phosphorylasedeficiency. // J. Clin Invest.
- 2003. –Jun.; V.111. – Issue 12. – P.1913-1921.440.Nomiyama T., Tanaka Y., Piao L., Hattori N., Uchino H., Watada H.,Kawamori R., Ohta S. Accumulation of somatic mutation in mitochondrial DNAand atherosclerosis in diabetic patients. // Ann. N. Y. Acad.
Sci. – 2004. – V.1011.– P.193-204.441.Nuntharatanapong N., Chen K., Sinhaseni P., Keaney J.F. Jr. EGF receptor-dependent JNK activation is involved in arsenite-induced p21Cip1/Waf1upregulation and endothelial apoptosis. // Am. J. Physiol. Heart. Circ. Physiol. –2005. – V.289. – Issue 1. – P.99-107.327442.Oeseburg H., Westenbrink B.D., de Boer R.A., van Gilst W.H., van derHarst P.
Can critically short telomeres cause functional exhaustion of progenitorcells in postinfarction heart failure? // J. Am. Coll. Cardiol. – 2007. – V.50. –P.1909-1913.443.Okuda K., Bardeguez A., Gardner J.P., Rodriguez P., Ganesh V., KimuraM., Skurnick J., Awad G., Aviv A. Telomere length in the newborn. // Pediatr.Res. – 2002. – V.52.
– P.377-381.444. Ono T., Isobe K., Nakada K., Hayashi J.I. Human cells are protected frommitochondrial dysfunction by complementation of DNA products in fusedmitochondria. // Nature Genetics. – 2001. – V.28. – P.272-275.445. Olivier M. The Invader® assay for SNP genotyping. // Mutat Res. – 2005. –June 3; V.573.
– Issue 1-2. – P.103–110.446. Orekhov A.N., Sobenin I.A., Sazonova M.A., Zhelankin A.V. Atherogenicmitochondrial mutations.// Journal of World Mitochondrial Society. – 2015. –V.1.– P.148.447. Orekhov AN, Melnichenko AA, Sobenin IA. Approach to reduction of bloodatherogenicity.// Oxid. Med. Cell. Longev. – 2014. – V.2014.
– 738679.doi: 10.1155/2014/738679.448. Orgel L.E.Ageing of clones of mammalian cells. // Nature. – 1973. – Jun. 22;V.243. – Issue 5408. – P.441-445. Review.449. Orlandi A., Bochaton-Piallat M.L., Gabbiani G., Spagnoli L.G. Aging, smoothmuscle cells and vascular pathobiology: implications for atherosclerosis. //Atherosclerosis. – 2006.
– V.188. – P.221-230.450. Osborn M., Caselitz J., Püschel K., Weber K. Intermediate filament expressionin human vascular smooth muscle and in arteriosclerotic plaques. //VirchowsArch. A. Pathol. Anat. Histopathol. – 1987. – V.411. – P.449-458.451.Ota Y., Tanaka M., Sato W., Ohno K., Yamamoto T., Maehara M., NegoroT., Watanabe K., Awaya S., Ozawa T. Detection of platelet mitochondrial DNAdeletions in Kearns-Sayre syndrome.
// Invest. Ophthalmol. Vis. Sci. – 1991. –V.32. – Issue 10. – P.2667-2675.328452. Owens G.K. Regulation of differentiation of vascular smooth muscle cells. //Physiol Rev. – 1995. – V.75. – P.487-517.453. Packard R.R., Libby P. Inflammation in atherosclerosis: from vascular biologyto biomarker discovery and risk prediction.
// Clin Chem. – 2008. – V.54. – Issue1. – P.24-38.454.Pávková Goldbergová M., Spinarová L., Spinar J., Pařenica J., Sišková L.,Groch L., Máchal J., Vašků A. Difference in angiotensinogen haplotypefrequencies between chronic heart failure and advanced atherosclerosis patients new prognostic factor? // Physiol. Res. – 2011. – V.60.
– Issue 1. – P.55-64.455.Peiretti F, Canault M., Morange P., Alessi M.C., Nalbone G. The two sidesof ADAM17 in inflammation: implications in atherosclerosis and obesity. // Med.Sci. (Paris). – 2009. – V.25. – Issue 1. – P.45-50.456. Pernow J., Shemyakin A., Böhm F. New perspectives on endothelin-1 inatherosclerosis and diabetes mellitus. // Life Sci. - 2012.
– V.91. – Issue 13-14. –P.507-516.457.Pham Y., Tu Y., Wu T., Allen T.J., Calkin A.C., Watson A.M., Li J.,Jandeleit-Dahm K.A., Toh B.H., Cao Z., Cooper M.E., Chai Z. Cell divisionautoantigen 1 plays a profibrotic role by modulating downstream signalling ofTGF-beta in a murine diabetic model of atherosclerosis. // Diabetologia. – 2010.
–V.53. – Issue 1. – P.170-179.458.Pinto A., Di Raimondo D., Tuttolomondo A., Buttà C., Milio G., Licata G.Effects of Physical Exercise on Inflammatory Markers of Atherosclerosis. // Curr.Pharm. Des. – 2012. – V.18. – Issue 28. – P.4326-4349.459.Pinto J.R., Siegfried J.D., Parvatiyar M.S., Li D., Norton N., Jones M.A.,Liang J., Potter J.D., Hershberger R.E. Functional characterization of TNNC1 rarevariants identified in dilated cardiomyopathy. // J.
Biol. Chem. – 2011. – V.286. –Issue 39. – P.34404-34412.460.Piťha J., Hubáček J.A., Piťhová P. The connexin 37 (1019C>T) genepolymorphism is associated with subclinical atherosclerosis in women with type 1329and 2 diabetes and in women with central obesity. // Physiol. Res. – 2010. –V.59. – Issue 6. – P.1029-1032.461.Polgár N., Járomi L., Csöngei V., Maász A., Sipeky C., Sáfrány E., SzabóM., Melegh B. Triglyceride level modifying functional variants of GALTN2 andMLXIPL in patients with ischaemic stroke.
// Eur. J. Neurol. – 2010. – V.17. –Issue 8. – P.1033-1039.462.Pollin T.I., Damcott C.M., Shen H., Ott S.H., Shelton J., Horenstein R.B.,Post W., McLenithan J.C., Bielak L.F., Peyser P.A., Mitchell B.D., Miller M.,O'Connell J.R., Shuldiner A.R. A null mutation in human APOC3 confers afavorable plasma lipid profile and apparent cardioprotection. // Science. – 2008. –V.322. – Issue 5908.
– P.1702-1705.463.Postnov A.Y., Sazonova M.A., Budnikov Y.Y., Khazanova Z.B., SobeninI.A., Orekhov A.N. Association of somatic mitochondrial mutations withatherosclerosis. // Atherosclerosis Suppl. – 2007. – V.8. – Issue 1. – P.46.doi: http://dx.doi.org/10.1016/S1567-5688(07)71126-1464.Pulkes T., Siddiqui A., Morgan-Hughes J.A., Hanna M.G. A novel mutationin the mitochondrial tRNA(Tyr) gene associated with exercise intolerance.
//Neurology. – 2000. – V.55. – Issue 8. – P.1210-1212.465.Puomila A., Viitanen T., Savontaus M.L., Nikoskelainen E., Huoponen K.Segregation of the ND4/11778 and the ND1/3460 mutations in four heteroplasmicLHON families. // J. Neurol. Sci. – 2002. – V.205. – Issue 1. – P.41-45.466.Qiu P., Shandilya H., D’Alessio J.M., O’Connor K., Durocher J., GerardG.F. Mutation detection using Surveyort nuclease. //Biotechniques. – 2004.
–V.36. – P.702–707.467.Rahman S., Taanman J.W., Cooper J.M., Nelson I., Hargreaves I., MeunierB., Hanna M.G., García J.J., Capaldi R.A., Lake B.D., Leonard J.V., SchapiraA.H. A missense mutation of cytochrome oxidase subunit II causes defectiveassembly and myopathy. // Am. J. Hum. Genet. – 1999. – V.65. – Issue 4. –P.1030-1039.330468. Rakesh K., Agrawal D.K. Cytokines and growth factors involved in apoptosisand proliferation of vascular smooth muscle cells. // Int.
Immunopharmacol. –2005. – V.5. – P.1487-1506.469.Reardon W., Ross R.J., Sweeney M.G., Luxon L.M., Pembrey M.E.,Harding A.E., Trembath RC. Diabetes mellitus associated with a pathogenic pointmutation in mitochondrial DNA. // Lancet. – 1992. – V.340. – Issue 8832. –P.1376-1379.470.Reitter A., Fischer D., Buxmann H., Nitschke Y., Rutsch F., Mottok A.,Hansmann M.L., Harms E., Louwen F., Schlosser R.
